fomannoxin: from Heterobasidion annosum; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 163013 |
| CHEMBL ID | 4099389 |
| MeSH ID | M0223672 |
| Synonym |
|---|
| fomannoxin |
| 63587-64-4 |
| 5-benzofurancarboxaldehyde, 2,3-dihydro-2-(1-methylethenyl)- |
| 2,3-dihydro-2-(1-methylethenyl)-5-benzofurancarboxaldehyde |
| Z1511751448 |
| DTXSID60979804 |
| 2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-carbaldehyde |
| CHEMBL4099389 |
Fomannoxin is a biologically active benzohydrofuran. It has been suggested to be involved in the pathogenicity of the root rotting fungus Heterobasidion annosum sensu lato.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Fomannoxin is a biologically active benzohydrofuran, which has been suggested to be involved in the pathogenicity of the root rotting fungus Heterobasidion annosum sensu lato. " | ( Biosynthesis of fomannoxin in the root rotting pathogen Heterobasidion occidentale. Broberg, A; Hansson, D; Karlsson, M; Menkis, A; Olson, K; Stenlid, J, 2012) | 2.17 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1437648 | Inhibition of LPS-induced COX-2 expression in mouse BV2 cells at 20 uM pretreated for 15 mins followed by LPS-stimulation after 24 hrs by western blot analysis relative to control | 2017 | Journal of natural products, 01-27, Volume: 80, Issue:1 | Bioactive Constituents from the Termite Nest-Derived Medicinal Fungus Xylaria nigripes. |
| AID1437647 | Inhibition of LPS-induced iNOS expression in mouse BV2 cells at 20 uM pretreated for 15 mins followed by LPS-stimulation after 24 hrs by western blot analysis relative to control | 2017 | Journal of natural products, 01-27, Volume: 80, Issue:1 | Bioactive Constituents from the Termite Nest-Derived Medicinal Fungus Xylaria nigripes. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||